|
|
| Research article summary (published 30 Oct 2009): |
Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma.
Full Abstract
We established a cancer stem (CS) cell line, U87CS, by means of spheroid culture of U87MG cells derived from glioblastoma (GBM) in neuronal stem cell medium. U87CS cells presented positive immunohistochemical staining for multidrug resistance (MDR)1 and CD133, a marker for a subset of leukemia and GBM CS cells. The gene expression of MDR1 and CD133 on U87CS cells increased by an average of 8.51 and 47.18 times, respectively, compared to the levels on U87MG cells by real-time quantitative RT-PCR. U87CS cells possessed stronger drug-resistance to conventional anti-cancer drugs, such as doxorubicin (Dox), etoposide (VP-16), carboplastin, and BCNU than U87MG cells. Double immunofluoresence staining showed co-expression of MDR1 and CD133 on U87CS cells transplanted into nude mice brains. In addition, we identified the crossreactivity of CD133 and MDR1 in a surgical specimen of GBM. Our results suggest that CS cells may be resistant to current chemotherapy and represent a novel target for GBM therapeutics.
Author information
Author/s: Nakai, Eiichi (E); Park, Kaechang (K); Yawata, Toshio (T); Chihara, Takahiro (T); Kumazawa, Ayano (A); Nakabayashi, Hiromichi (H); Shimizu, Keiji (K);
Affiliation: Department of Neurosurgery, Medical School, Kochi University, Kochi, Japan.
Journal and publication information
Publication Type: Journal Article
Journal: Cancer investigation (Cancer Invest), published in England. (Language: eng)
Reference: 2009-Nov; vol 27 (issue 9) : pp 901-8
Dates: Created 2009/10/16; Completed 2009/10/29;
PMID: 19832037, status: MEDLINE (last retrieval date: 10/29/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Expression of multidrug resistance genes in normal and cancer stem cells.
30 May 2008 - Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?
4 Feb 2007 - Glioblastoma and stem cells.
30 Dec 2007 - CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
29 Apr 2007 - Promoter hypomethylation regulates CD133 expression in human gliomas.
29 Sep 2008 - Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
30 Mar 2008 - Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
16 Oct 2006 - CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.
13 Feb 2008 - Targeting brain-tumor stem cells.
30 Jan 2007 - Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.
5 Dec 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.